Literature DB >> 15868372

Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis.

Hideki Masuda1, Yasuo Takahashi, Satoshi Asai, Akihiro Hemmi, Tadatoshi Takayama.   

Abstract

BACKGROUND: The aim of the present work was to assess osteopontin (OPN) expression in the colon tissues of ulcerative colitis (UC), Crohn's disease (CD), and diverticulitis (Div) patients.
METHODS: This study included three groups: the UC group, CD group, and Div group. Immunohistochemical staining was performed, using an immunoperoxidase method.
RESULTS: Regarding OPN expression in intestinal epithelial cells, no difference was noted among the three groups. However, in the submucosa of the UC group, the ratio of two types of large cells (oval and spindle-shaped) expressing OPN was 61.2 +/- 14.4% (mean +/- SD), which was significantly higher than that in the CD group (14.9 +/- 7.0%; P < 0.05) and that in the Div group (11.2 +/- 6.1%; P < 0.05). In addition, in the UC group, the ratio of these cells in the subserosa (50.1 +/- 15.0%; mean +/- SD) was significantly higher than that in the CD group (16.9 +/- 6.2%; P < 0.05) and that in the Div group (12.6 +/- 5.7%; P < 0.05). In a serial section study, the oval-shaped cells were stained for anti-CD 68, while the spindle-shaped cells were stained for anti-vimentin.
CONCLUSIONS: OPN in two types of large colon-infiltrating cells is possibly related to one of the pathogenic factors of UC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868372     DOI: 10.1007/s00535-005-1567-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  11 in total

1.  Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery.

Authors:  Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Plasma osteopontin predicts inflammatory bowel disease activities.

Authors:  Shihoko Komine-Aizawa; Hideki Masuda; Takerou Mazaki; Motomi Shiono; Satoshi Hayakawa; Tadatoshi Takayama
Journal:  Int Surg       Date:  2015-01

3.  Osteopontin ablation attenuates progression of colitis in TNBS model.

Authors:  Helieh S Oz; Jian Zhong; Willem J S de Villiers
Journal:  Dig Dis Sci       Date:  2011-12-16       Impact factor: 3.199

4.  Osteopontin: participation in inflammation or mucosal protection in inflammatory bowel diseases?

Authors:  Fengyuan Chen; Hongchun Liu; Qiang Shen; Shengzhong Yuan; Lin Xu; Xunquan Cai; Jingjing Lian; Shi-yao Chen
Journal:  Dig Dis Sci       Date:  2013-01-30       Impact factor: 3.199

Review 5.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

6.  The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.

Authors:  Jürgen Glas; Julia Seiderer; Corinna Bayrle; Martin Wetzke; Christoph Fries; Cornelia Tillack; Torsten Olszak; Florian Beigel; Christian Steib; Matthias Friedrich; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

7.  Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity.

Authors:  Takahiko Toyonaga; Hiroshi Nakase; Satoru Ueno; Minoru Matsuura; Takuya Yoshino; Yusuke Honzawa; Ayako Itou; Kazuyoshi Namba; Naoki Minami; Satoshi Yamada; Yorimitsu Koshikawa; Toshimitsu Uede; Tsutomu Chiba; Kazuichi Okazaki
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.

Authors:  Rikako Ishigamori; Masami Komiya; Shinji Takasu; Michihiro Mutoh; Toshio Imai; Mami Takahashi
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

9.  Innate CD8αα+ cells promote ILC1-like intraepithelial lymphocyte homeostasis and intestinal inflammation.

Authors:  Ali Nazmi; Kristen L Hoek; Michael J Greer; Maria B Piazuelo; Nagahiro Minato; Danyvid Olivares-Villagómez
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

10.  Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.

Authors:  Evangelia Kourepini; Maria Aggelakopoulou; Themis Alissafi; Nikolaos Paschalidis; Davina C M Simoes; Vily Panoutsakopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.